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Summary The mean extracellular pH (pHe) within solid tumours has been found to be lower than in normal tissues. Agents which cause intracellular acidification at low pHe might have selective toxicity towards cells in
tumours. Weak acids (or their anions) with pKa values in the range of 4-6 have a higher proportion of molecules in the uncharged form at low pHe and can diffuse more rapidly into cells. The effects of organic acids including succinate, monomethyl succinate and malonate to acidify cells have been evaluated under conditions of different pHe in the acidic range. These weak acids caused intracellular acidification of murine EMT-6 and human MGH-Ul cells in a concentration and pHe dependent fashion. At concentrations of 1Omm and above, these acids also caused in vitro cytotoxicity to these cells at low pHe (<6.5). The rate and
extent ofcellular acidification caused by these weak acids, and their cytotoxicity at low pHe, were enhanced by
exposure to amiloride and 5-(N-ethyl-N-isopropyl)amiloride (EIPA), agents which inhibit Na+/H+ exchange, and hence the regulation of intracellular pH. Acid dependent cytotoxicity was also investigated in a murine solid tumour using the endpoints of growth delay and colony formation in vitro following treatment in vivo. Agents were tested alone or with 15 Gy X-rays to select a population of hypoxic (and presumably acidic) cells. Achievable serum concentrations of succinate were about 1 mm and no antitumour activity of succinate was detected when used in this way. It is concluded that weak acids are selectively taken up into cells, and can
cause selective cellular acidification and toxicity, at low pHe in culture. Weak acids that are normal cellular metabolites are not toxic in vivo, but weak acids carrying cytotoxic groups offer the potential for selective
uptake and toxicity under the conditions of low pHe that exist in many solid tumours.
It has been shown that solid tumours of both humans and
animals contain acidic regions (Vaupel et al., 1989; Wike-
Hooley et al., 1984). The mean extracellular pH (pHe) within
solid tumours has been shown from measurements with
microelectrodes to be in the range of 6.5-7.0, which is about
0.5 units lower than in normal tissues. Extracellular acidity in
tumours probably occurs because of relatively poor vas-
cularisation as compared to normal tissues, leading to the
poor clearance of acids produced by metabolism. Measure-
ments of intracellular pH (pHi) in solid tumours made by
nuclear magnetic resonance (NMR) spectroscopy have sug-
gested that mean values of pHi are similar to those in normal
tissues (Grant Steen, 1989; Vaupel et al., 1989). Tumour cells
are able to tolerate acidic pHe by using their buffering
ability, and by activating ion exchange mechanisms which are
present in the cell membrane, to maintain pHi close to the
physiological range. Important membrane exchangers which
regulate pHi in the acidic range are the Na+/H+ antiport and
the Na+ dependent Cl-/HCO-3 exchanger (Madshus, 1988;
Tannock & Rotin, 1989).
Previous studies in the present laboratory have shown that
the ionophores nigericin and carbonylcyanide-3-chlorophen-
ylhydrazone (CCCP) cause selective acidification of cells at
low pHe; these agents are toxic at low but not at
physiological pHe (Newell & Tannock, 1989; Rotin et al.,
1987) suggesting that toxicity is due to cellular acidification
rather than to effects on mitochondria. The cytotoxicity of
these agents was increased when they were used in combina-
tion with amiloride which inhibits the Na+/H+ antiporter,
and with the stilbene derivative 4,4'-diisothiocyanostilbene
2,2-disulfonic acid (DIDS) which inhibits the Na+-dependent
Cl-/HCO-3 exchanger.
Weak acids might also allow selective acidification of cells
in an acidic environment. The protonated forms of weak
acids are more membrane permeable than their charged
anionic forms. Thus exposure of cells to weak acids is
expected to result in an acute acid load to the cytoplasm
which increases at lower pHe, where a higher proportion of
acid is in the protonated and uncharged form. Preliminary
evidence for acidification of tumour cells when exposed to
the organic acid succinate was obtained previously (Dobrow-
sky et al., 1991). Also, production of succinic acid by bacteroides, a group of anaerobic bacteria, has been shown
to lead to a low pHe in abscesses and to cause intracellular
acidification of granulocytes leading to loss of their viability (Rotstein et al., 1988).
In the present paper we address the hypothesis that
organic acids may cause acidification and death of cells at
low pHe, and that these effects are increased by agents which
inhibit regulation of pHi. We examine further whether such
effects might allow selective treatment of tumour cells that
are exposed to an acidic extracellular environment in vivo.
Materials and methods
Reagents
Succinic acid, malonic acid, succinic acid monomethyl ester, butyric acid, propionic acid, ATP-bioluminiscent assay kit
and antimycin A were obtained from the Sigma Chemical
Co., St. Louis, MO, USA. 2',7'-bis(2-carboxyethyl)-5 (and 6-) carboxyfluorescein acetyomethyl ester (BCECF-AM) was
purchased from Molecular Probes, Eugene, Oregon, USA.
Radiolabelled 2,3-'4C-succinic acid (Sp. activity = 56 mCi
mmol ') was obtained from New England Nuclear, Missis-
sauga, Ontario, Canada.
Cells
The murine mammary sarcoma cell line EMT-6 (obtained originally from Dr R. Sutherland, Rochester, NY, USA) and
the human bladder carcinoma cell line MGH-Ul (obtained originally from the Urology Research Laboratory, Mas-
sachussetts General Hospital, Boston, MA, USA) were main-
tained in a-minimum essential medium (a-MEM) sup- plemented with 0.1 mg ml-' of kanamycin and 5% foetal
bovine serum (FBS). These cell lines were chosen because
their mechanisms of regulation of pHi have been studied in
detail and because they allow comparison of effects against human and rodent cell lines (Boyer & Tannock, 1992). Both
cell lines were reestablished from frozen stock at about 3
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month intervals and were tested routinely for mycoplasma
and were not contaminated. Cells were grown as monolayers
in tissue culture flasks and were detached from flasks with
0.05% trypsin and 0.53 mM ethylenediaminetetraacetic acid
(EDTA) (Gibco, Grand Island, NY, USA). All experiments
were performed with exponentially growing cells.
Measurement ofintracellular pH
Intracellular pH (pHi) was determined by using the pH
sensitive fluorescent probe BCECF-AM (Rink et al., 1982).
Cells at a concentration of 1.5 x 106ml-' in N-2-hydroxy-
ethylpiperazine-N-ethanesulfonic acid (Hepes) buffered med-
ium at pHe 7.4 were loaded with the esterified form of the
fluorochrome, BCECF-AM, by incubation in the dark with
2 tg ml-' for 20 min at 37°C. Cells were washed by cen-
trifugation and 80 jil of the cell suspension containing
-5 x I05 cells was then added to a polystyrene cuvette
containing NMG (140 mM N-Methyl-D-glucamine) or Na+
(140 mM NaCl) each containing 1 mM KCl, 1 mM CaC12,
1 mM MgCl2 and 5 mM glucose, buffered to different values
of pHe with 20 mM Tris/Mes. The cuvette was temperature
controlled (37°C) and stirred continuously using a magnetic
flea. The uncharged form of BCECF-AM diffuses into the
cell where it is cleaved by nonspecific esterases to form the
charged, impermeant BCECF. Fluorescence was monitored
with excitation and emission wavelengths set at 495 nm and
525 nm respectively. Weak acids (or their anionic forms) were
titrated to desired values of pHe with KOH and were added
to the cuvette in varying concentrations, and change in pHi
was monitored with time. Calibration of pHi was performed
after each experiment by adding 2;g ml-' nigericin to a
cuvette of BCECF-containing cells in K+ buffer (identical to
the Na buffer with isoosmotic replacement of KCl for NaCl).
Nigericin sets pHi equal to pHe under these conditions and
fluorescence was measured at varying pHe after sequential
addition of aliquots of 1 M solutions of Mes[2-(N-
morpholino)ethanesulfonic acid] (Mes) or Tris. This method
ofcalibration has been supplemented in some experiments by
lysing the cells and comparing fluorescence with
measurements of pHe, with an appropriate correction for
intracellular quenching of BCECF. There was an approx-
imately linear relationship between pHi and fluorescence
intensity in the range of pHi 6.0 to 7.5. The activity of the
Na+/H+ exchanger was estimated from the rate of change of
pHi following addition of 100 mM Na+ to acid-loaded cells
suspended in Na+ free (NMG) solution (Madshus, 1988;
Tannock & Rotin, 1989).
Assessment ofcytotoxicity in vitro
Toxicity of weak acids at varying pHe was assessed by using
the endpoint of colony formation. Five ml aliquots of a
suspension containing 106 cellsml' in a-MEM plus FBS
buffered to the required pHe were added to small glass vials.
The cells were stirred continuously at 37°C, and humidified
air (plus 5% C02) flowed through the vials, as described
previously (Rotin et al., 1987). Weak acids were buffered to
the same pHe and added to the suspension 15 min later. At
desired times after adding weak acids, 0.5 ml samples of the
cell suspension were withdrawn by passing a long needle
attached to a syringe through the gas outlet tube. The cells
were washed and resuspended in a-MEM plus 5% FBS at
pH 7.3, diluted, and plated in triplicate petri dishes. Colonies
were stained with methylene blue and counted 9 to 13 days
later. Surviving fraction was calculated as the ratio of plating
efficiencies of treated and control plates exposed at the same
pHe. Plating efficiency for control plates incubated at pHe
6.0 or above was always greater than 50%.
Uptake ofradiolabelled succinate
Experiments involving uptake of radioactive succinate into
EMT-6 cells were carried out in medium containing 140 mM
NaCl, 1mM KCI, 1 mM MgCl2, 1mM CaCl2 which was
buffered with Mes/Tris at 37°C to the desired pH; mixing was
performed with a magnetic flea. Exponentially growing cells
were trypsinised and washed with buffer solution at different
pH without succinate. Cells were centrifuged and resus-
pended in isotonic solution at different pH containing 2 ftM
antimycin A to inhibit the oxidation of succinate (Spencer,
1976). After preincubation for 20 min, cells (107ml-') were
exposed to buffer at different pH which also contained 2.1JM
antimycin A, 5 mM unlabelled succinate and labelled suc-
cinate at a concentration 4 .tCi ml-' (2 ,.Ci ml-' in a repeat
experiment). After different time periods, 0.3 ml aliquots were
removed and nigericin was added to a final concentration of
5pM; nigericin has been shown previously to cause almost
complete inhibition of succinate transport (Spencer, 1976).
Cells were centrifuged through a dibutylpthalate:corn oil
(10:3) mixture to separate them from the buffer solution.
Radioactivity was counted in the pellet using a liquid scintil-
lation counter (LS 330; Beckman).
Effects of weak acids on tumour growth
Maximum tolerable doses of weak acids were determined in
preliminary experiments by injecting different doses intra-
peritoneally into small groups of three mice. We determined
the maximum dose at which animals survived with no abnor-
mal behaviour, and with minimal weight loss. This dose was
then used in subsequent experiments to study effects on
growth of the KHT fibrosarcoma in syngeneic C3H/HeJ
mice. This tumour is known to develop an acidic microen-
vironment with a mean value of pHe of 6.84 ± 0.06, and
methods of transplantation and assessment of growth delay
have been described previously (Newell et al., 1992).
Appropriate dilutions of organic acids were titrated with
NaOH to neutral pH and were injected intraperitoneally in
volumes of 0.01 to 0.03 ml per gram body weight. Groups of
mice bearing tumours with a mean diameter of 8.5 mm
received either a single injection of succinate or monomethyl
succinate or a course of four injections given at hourly
intervals. To seek evidence for selective toxicity to hypoxic
cells, a dose of 15 Gy was given immediately prior to a single
injection, or between the second and third injections when
multiple doses of the acid were given. Most cells which
survive this radiation dose are expected to be hypoxic. Local
tumour irradiation was delivered by using a specially
designed 100 KV X-ray machine at a dose rate of
11.4 Gy min-' (Newell et al., 1992). For assessment of the
effect of treatment on tumour growth, tumour diameter was
estimated on coded mice every second day by passing the
tumour-bearing leg through a series of graded holes drilled in
lucite. Mice were killed humanely when their tumours
attained a mean diameter of 14 to 15 mm. Tumour growth
curves were constructed from a previously defined calibration
curve relating tumour weight to mean diameter.
Effects ofsuccinate on tumour cell survival in vivo
We assessed clonogenic survival following treatment of the
EMT-6 tumour, which is also known to develop an acidic
microenvironment (mean pHe = 6.75 ± 0.06; Newell et al.,
1992). Balb/c mice weighing 20-24 g were injected with
5 x 105 EMT-6 cells into the hind flank. The tumours were
allowed to grow for 7 days at which time the animals were
randomised into groups to receive treatment. Treatments
included four intraperitoneal injections of 0.01 ml g-' body
weight of 500 mM Na-succinate or saline (controls) given at
1 h intervals; 15 Gy local X-irradiation given alone or
between the second and third injections of Na-succinate;
5-(N-ethyl-N-isopropyl) amiloride (EIPA, 20JiMkg-' body
weight) injected immediately after irradiation together with
the same schedule of succinate injections; and hydralazine
(10 mg kg-' body weight) injected with EIPA in a similar
schedule. Hydralazine was given to try to inhibit tumour
blood flow and thereby lower tumour pH (Lin & Song, 1990;
Newell et al., 1992; Thomas et al., 1992). Tumours were
removed from the mice 24 h after the last treatment and cell1082 A.R. KARURI et al.
survival was estimated by using an in vitro clonogenic assay
as described previously (Thomson & Rauth, 1974).
Measurement ofsuccinate in murine serum
Succinate was assayed enzymatically by using a Boehringer
Mannheim assay kit. Briefly, blood samples were collected
from anaesthetised mice by puncturing the heart and serum
was prepared from the blood by centrifugation. Measurement
of the concentration of succinic acid in the serum utilises the
following principle. Succinate is converted by the enzyme
succinyl-CoA synthetase in the presence of inosine-5'-
triphosphate (ITP) and Coenzyme A (CoA) to succinyl CoA
with simultaneous formation of inosine-5'-diphosphate (IDP)
and inorganic phosphate. Inosine-5'-diphosphate reacts with
phosphoenol pyruvate in the presence of pyruvate kinase to
pyruvate and ITP. Pyruvate is then reduced by NADH in the
presence of lactate dehydrogenase (LDH). The amount of
NADH oxidised in the above reaction is proportional to the
amount of succinic acid originally present. Change in concen-
tration of NADH was measured by its absorbance at
340 nm.
Results
Cellular acidification
Experiments which characterise the effects of weak acids to
cause intracellular acidification are described in Figures 1-3
and in Table I. All experiments were repeated to ensure
reproducibility.
When mammalian cells grown at physiological pHe (-7.3)
are added to medium buffered to a lower pHe there is a slow
fall in pHi to a new equilibrium value; for EMT-6 cells at
pHe 6.5 this equilibrium is about 6.9 (Table I and Figure 1).
The monocarboxylic acids propionic acid, butyric acid and
monomethyl succinic acid, and the dicarboxylic acids malonic
acid and succinic acid all caused a marked increase in
acidification of EMT-6 cells (Table I) and MGH-Ul cells
(data not shown) at pHe 6.5. When cells, formerly grown at
pHe 7.3 in a-MEM, were added to buffers containing these
acids the rate of acidification was higher in NMG-containing
buffer than in Na+-containing buffer (Figures la and b)
a
presumably because the presence of Na+ allowed cellular
acidification to be opposed by the activation of the Na+/H+
exchanger. Acidification of cells in the presence of Na+ and
the Na+/H+ inhibitor EIPA was more rapid than in Na+-
buffer, and only slightly slower than that observed in Na+-
free NMG containing buffer (Figure 1c).
The rate of acidification was dependent on concentration
and on pHe for all acids used (Figures 1 and 2). The decrease
in pHi was most rapid for cells exposed to monocarboxylic
acids such as propionic acid, butyric acid and monomethyl
succinic acid in NMG containing buffer (Table I) and these
acids were able to acidify cells at neutral pHe 7.1; dicarb-
oxylic acids did not cause cellular acidification at pHe 7.1
(Figure 2).
All mammalian cells express the Na+/H+ exchanger which
allows exchange of extracellular Na+ for intracellular H+
under conditions when cells becomes acidified (Madshus,
1988; Tannock & Rotin, 1989). In order to measure Na+-
dependent pHi recovery from intracellular acidification by
these weak acids, cells containing BCECF were exposed to
different concentrations of weak acids in NMG-containing
buffer at different pHe. When pHi had fallen to a low value,
100 mM NaCl was added, and Na+/H+ exchanger activity
was measured by the rate of alkalinisation. Recoverability of
pHi after acidification by these weak acids is concentration
and pHe dependent but pHi returned to neutral in the
presence of NaCl after addition of monocarboxylic acids at
normal pHe (Figure 2). Exposure of cells to dicarboxylic
acids (or their anions) such as succinate or malonate caused
them to have slower recovery of pHi than exposure to
monocarboxylic acids. At a concentration of 50mM succinate
there was almost complete inhibition of the Na+/H+
exchanger at pHe 6.1.
The above experiments have shown that organic acids
increase the rate and extent of acidification when cells are
placed acutely in medium at low pHe which contains them.
However cells in an acidic microenvironment in tumours may
be chronically adapted to low pHe. We have therefore per-
formed additional experiments to determine whether organic
acids were able to acidify cells that were adapted to low pHe.
When EMT-6 cells were exposed to Na+ buffer at different
pHe in the acidic range the cytoplasmic pHi equilibrated
after about 30 min at a value which was dependent on (but
higher than) pHe (Figure 3a). Addition of succinate or
b c
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Figure 1 Changes in intracellular pH (pHi) of EMT-6 cells (previously grown in a-minimum essential medium (aoMEM) at
extracellular pH (pHe) 7.3) as a function of time after adding cells to N-methyl-D-glucamine (NMG) buffer a, or Na+ buffer b and
c, at pHe 6.5; the buffer contained double-distilled water (DDL) or different concentrations of succinate a-c, with or without
5-(N-ethyl-N-isopropyl) (EIPA, 10pM; c).
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Figure 2 Changes in intracellular pH (pHi) of EMT-6 cells as a
function of time after adding them to N-methyl-D-glucamine
(NMG) buffer containing 20 mM potassium propionate a, or
20 mm succinate b, at various extracellular pH (pHe). Also shown
is the recovery of pHi (due to Na+/H+ exchange) after adding
NaCI to a final concentration of 100 mm (solid lines) as com-
pared to no addition of NaCl (dashed lines).
monomethyl succinate (data not shown) to cells that were
adapted to acidic conditions caused acidification, and inhibi-
tion of the residual Na+/H+ activity by amiloride or EIPA
led to further acidification (Figure 3a). The relationship
between pHi and pHe under equilibrium conditions is shown
in Figure 3b; cells are able to maintain values of pHi above
pHe under acidic conditions. Addition of weak acids shifted
the equilibrium between pHe and pHi, such that the cells
maintained a smaller pH gradient across the cell membrane
under acidic conditions and this effect was enhanced in the
presence of EIPA (Figure 3b).
Uptake ofradioactive succinic acid
It has been reported previously that the rate of cellular
uptake of succinate is increased at low pHe (Spencer, 1976).
We measured the uptake of '4C-succinate at intervals from 1
to 10min after adding it to medium at pHe 6.13 and 7.15
(Figure 4). Our experiments confirm that the rate of uptake
of radiolabelled succinate is increased at low pHe.
Acids cause in vitro cytotoxicity
Exposure of exponentially-growing EMT-6 cells to succinate,
monomethyl succinate or malonate caused cytotoxicity that
was dependent on the duration of exposure, the concentra-
tion of acids used, and on pHe (Figure 5a and b). Toxicity
was observed at pHe 6.5 and below, and cell killing increased
as pHe was reduced.
Since amiloride and EIPA increase cellular acidification
(Figures 1 and 3), presumably by inhibiting Na+/H+
a
20 mM Succinate
20 mmv Succinate +
0.1 mM Amiloride
20 mm Succinate +
I-1 I I I 10 FM EIPA
10 20 30 40
Time (min)
b
7.0 F
I
CL
Control
,20 mm Succinate
10 FLM EIPA +
20 mm Succinate
6.5 F
6.0
.
6.0 6.5 7.0
Extracellular pH (pHe)
Figure 3 a, Decrease of intracellular pH (pHi) during adaptation of EMT-6 cells in Na+ buffer at extracellular pH (pHe) 6.5 for
30 min and following the addition of 20 mm succinate alone or in combination with 100ZlM amiloride or 10O M 5-(N-ethyl-N-
isopropyl) (EIPA). b, Relationship between pHe and pHi following 30 min exposure of EMT-6 cells at pHe6.1, 6.5 or 7.1 to Na+
buffer alone, or containing 20 mm succinate with or without 1OIM EIPA.
Table I Acidification ofEMT-6cellswhenadded to N-methyl-D-glucamine (NMG) buffer atextracellularpH
(pHe) 6.5 containing different acids at a concentration of 20 mM
Minimum pHi ApHi in I min
Organic acids pKa Structures (mean ± s.e.m.) (mean ± s.e.m.)
A > Monocarboxylic acids
Propionic acid 4.87 CH3CH2COOH 6.54 ± 0.08 0.45 ± 0.04
Butyric acid 4.82 CH3CH2CH2COOH 6.56 ± 0.05 0.40 ± 0.06
Monomethyl 4.21 HOOCCH2CH2COOCH3 6.43 ± 0.06 0.54 ± 0.07
Succinic acid
B> Dicarboxylic acids
Malonic acid 2.83 & 5.69 HOOCCH2COOH 6.66 ± 0.04 0.10 ± 0.02
Succinic acid 4.21 & 5.64 HOOCCH2CH2COOH 6.58 ± 0.06 0.11 ± 0.03
C> Buffer only - 6.95 ± 0.03 0.03 ± 0.02
(Control)
pHi, intracellular pH.
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Figure 4 Uptake of labelled succinate expressed as counts per
min (CPM) per 3 x 106 EMT-6 cells. Values are mean ± s.e. of
multiple samples obtained in a single experiment. A repeat experi-
ment gave essentially identical results when normalised by the
quantity of radiolabelled succinate that was used (4jLCiml-I in
the experiment shown; 21Ci ml-I in the repeat experiment).
exchange, we studied the cytotoxicity of weak acids in com-
bination with amiloride or EIPA (Figure 6). Amiloride or
EIPA showed minimal toxicity when used alone in the range
of pHe 6.0-7.0. When 20 mM succinate or monomethyl suc-
cinate were used in combination with 100tLM amiloride or
1OJM EIPA at pHe 6.1, there was enhancement in cytotox-
icity due to the weak acids and effects were much greater
when using the potent analogue EIPA (Figure 6). Thus
although Na+/H+ exchange activity is inhibited at low pHe
in the presence of succinate (Figure 2b), residual activity
appears to be important in protecting the cells from cytotox-
icity.
Responses oftumours to in vivo treatment
Untreated KHT tumours grew from a mean diameter of
8.5 mm ('0.25 g) to 12.5 mm (-1.0 g) in 2-3 days and
single or multiple doses of succinate or monomethyl suc-
cinate had at most minimal effects to influence the rate of
tumour growth. Representative data for multiple doses of
succinate are shown in Figure 7. Irradiation of KHT
tumours with 15 Gy X-rays produced growth delay of about
10 days. This growth delay in irradiated mice was not in-
creased significantly by administration of single or multiple
doses of succinate (Figure 7) or monomethylsuccinate (data
not shown) at maximal tolerated doses.
Since hydralazine can reduce tumour blood flow and mean
pHe we assessed the effects of succinate ( ± EIPA) with or
without radiation on clonogenic survival of EMT-6 tumours
in Balb/c mice that had received hydralazine. Tumour cell
survival was measured directly using an in vitro clonogenic
assay. Only X-radiation produced a cytotoxic effect on EMT-
6 cells, and there was no additional effect of succinate (data
not shown).
Concentration ofsuccinate in serum
The serum concentration of succinate was assayed after injec-
tion of a single dose as used in the above experiments. As
shown in Table II, the maximum serum concentration of
succinate was about -1.l.5 mM, and this is not in the range
which leads to cytotoxicity in tissue culture.
Discussion
In the present studies we have investigated the potential of
weak acids to cause intracellular acidification and cytotox-
icity in an acidic microenvironment as can be found in some
regions of solid tumours. The results indicate that weak acids
Figure 5 Survival of EMT-6 cells in a-minimum essential
medium (a-MEM): a, in the presence of diluent (control) or of
different concentrations of succinate at extracellular pH (pHe)
6.1. b, In the presence of 50 mm Na malonate at different pHe
(control represents diluent at pHe 6.1). Points represent mean and
range from triplicate plates.
alone or in combination with agents that inhibit the Na+/H+
antiporter (and hence pHi regulation) cause intracellular
acidification and cytotoxicity at low pHe (<6.5) but exert
little or no cytotoxicity at physiological pHe. Unfortunately,
the relative low concentrations achievable in vivo make it
unlikely that this mechanism will lead to antitumour effects
at tolerated doses when using the organic acids which were
studied here.
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Succinate
11
Radiation
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Days after treatment
b Figure 7 Growth curves for the KHT tumour following treat-
ment with succinate (0.01 ml g'I body weight of 500 mM Na
succinate given four times at 1 h intervals) alone or with 15-Gray
X-radiation given between the second and third injections of
succinate. (Mean ± s.e.m. for eight animals per point are
indicated.)
Table II Serumconcentration ofsuccinatefollowing injection (i.p.) of
500 mM (0.01 mlg-' body wt.) Na-succinate
Time (h)
Figure 6 Survival of EMT-6 cells in a-minimum essential
medium (at-MEM) in the presence of a, 20 mm succinate or
monomethyl succinate with or without 100 iM amiloride, or b,
succinate 20 mm with or without 10 iM 5-(N-ethyl-N-isopropyl)
(EIPA) at extracellular pH (pHe) 6.1. Note the different ordinate
scales in parts a and b. Control cultures were treated with diluent
at pHe 6.1. Points represents mean and range from triplicate
plates.
The presumed mechanism of intracellular acidification by
weak acids is increased diffusion of a weak acid into cells at
low pHe, when a greater proportion is in the protonated and
uncharged form than at pHe 7.0. Once inside the cell, the
pHi is well above pKa, leading to dissociation of the pro-
tonated form and acidification. For example, there are three
Time after injection
(min)
10
30
60
120
Succinate concentration
Mean (range in mM)a
0.46 (0.31-0.55)
0.95 (0.21-1.33)
1.31 (0.88-1.62)
1.16 (0.51-1.46)
an = 4 determinations.
Table III Concentration of ionisation forms of succinic acids at
different pH values (total concentration 10mM)
pH HAH HA- A=
6.0 0.019 1.6 8.38
6.5 0.002 0.585 9.41
6.8 0.00054 0.292 9.71
7.0 0.00022 0.187 9.81
forms of the divalent acid succinate which exist in solution,
i.e. HAH, HA- and Am (where A represents the succinate
anion). The relative proportions of each component at any
level of pH may be calculated from the pKa values using the
Henderson-Hasselbalch equation, as illustrated in Table III.
If the uptake of succinic acid into the cell is proportional to
the extracellular concentration of the un-ionised form, the
rate of entry should be 10-fold higher at pHe 6.5, and 86-fold
higher at pHe 6.0, as compared to pHe 7.0. Our experimental
measurements of uptake of radiolabelled succinate show that
this is indeed dependent on pH, but with a rate of uptake
that is 2-3 times higher at pHe 6.13 compared with
pHe 7.15. This lower ratio of uptake rates is probably due to
higher levels ofprotonated acids inside the cell at lower levels
of pHi (and pHe) with a consequent reduction of transmem-
a
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brane gradient for the protonated acid. Monocarboxylic
acids are expected to cause more rapid acidification than
dicarboxylic acids, since a higher proportion is in the neutral
form, and we found that they could acidify cells in the
physiological range of pHe in NMG buffer. Also the
presence of a monocarboxylic acid transporter in the plasma
membrane (Deuticke et al., 1982) may contribute to uptake
of monocarboxylic acids, and to the partially ionised form
(HA-) of dicarboxylic acids.
We found that weak acids were toxic to cultured cells only
at low pHe, and cell death was probably caused by cellular
acidification. Low pHi can interfere with a variety of cellular
processes including energy metabolism, and persistence of
low pHi may lead to irreversible injury to the cell. However,
measurement of ATP (using chemoluminescence) as an
indicator of energy metabolism after 2 or 4 h exposure to
succinate (50mM) at pHe 6.2 or 7.2 showed no significant
difference as compared to control (data not shown).
Cells are able to resist intracellular acidification by using
intracellular buffers and by activating the Na+/H+ antiport
and the Na+ dependent HCO-3/Cl- exchanger (Madshus,
1988; Tannock & Rotin, 1989). We showed that Na+/H+
exchange activity contributed substantially to recovery of
pHi, except when a high concentration of succinate was
applied at low pHe (6.1). Cells which were exposed to suc-
cinate or monomethyl succinate in the presence of the Na+/
H+ exchanger inhibitor amiloride, or its more potent
analogue EIPA had greater and more sustained acidification
and greater cytotoxicity below pHe 6.5; thus even low
residual Na+/H+ exchange activity appear to protect cells
against cytotoxicity due to cellular acidification. Similar
results were observed previously when cells were exposed to
the ionophores nigericin or CCCP at low extracellular pHe
(Newell & Tannock, 1989; Rotin et al., 1987).
The present experiments suggest that, at low pHe, weak
acids can cause lethal injury to cultured cells. In solid
tumours, the mean value of pHe is often low (Wike-Hooley
et al., 1984; Vaupel et al., 1989). Values of pHe are likely to
be lowest in nutrient deprived (presumably hypoxic) regions
of tumours because of production of lactic acid and hydro-
lysis of ATP, and insufficient clearance of metabolically pro-
duced acids. We have studied the in vivo effects of weak acids
by using them alone, or with radiation to select a target
population of hypoxic and poorly nourished cells. We have
also employed hydralazine, which has been reported to
decrease pHe in tumours by inhibiting blood flow (Lin &
Song, 1990), with maximum tolerable doses of succinate and
EIPA, but found no toxicity following in vivo treatment with
weak acids for any of these conditions. Failure to achieve
toxicity in vivo is most likely due to failure to achieve an
adequate concentration in plasma. The maximum concentra-
tion of succinate following a single injection of a maximally
tolerated dose was approximately 1.5 mM which is below the
toxic range. Since the buffering capacity of cells is high
(20-30 mM/pH unit; Boyer & Tannock, 1992), use of weak
acids which transport protons into cells together with their
anions will probably require millimolar concentrations to
achieve cellular acidification.
Although weak acids such as succinate, which are normal
cellular metabolites, are unlikely to have therapeutic effects,
the present work emphasises the potential for using the low
pHe in tumours to obtain selective toxicity. Toxicity might be
induced by intracellular acidification, but the strategy of
using ionophores, which remain in the cell membrane and
which can acidify cells at micromolar concentrations, remains
the more promising approach (Maidorn et al., 1993). The
selective uptake of weak acids at low pHe (Figure 4) has
therapeutic potential if the acids carry cytotoxic moieties that
act against intracellular targets. Increased activity at low pHe
has been reported for some conventional anticancer drugs
that are weak acids, such as chlorambucil and melphalan
(Jahde et al., 1989; Mikkelsen & Wallach, 1982), although
the success of the approach will depend on the intrinsic
toxicity of the drug that is concentrated in cells under acidic
conditions. Some previous investigators have argued for the
selective activity of cytotoxic agents that are weak bases, but
since values of pHi in tumours are normal whereas values of
pHe are often low, it is the specific design of cytotoxic weak
acids which is likely to offer therapeutic advantage through
the mechanism of selective uptake into tumour cells.
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